ES2093980T3 - Proceso de reduccion asimetrica, enzimatica, para producir derivados de 4h-tieno(2,3-6)tiopirano. - Google Patents

Proceso de reduccion asimetrica, enzimatica, para producir derivados de 4h-tieno(2,3-6)tiopirano.

Info

Publication number
ES2093980T3
ES2093980T3 ES93918065T ES93918065T ES2093980T3 ES 2093980 T3 ES2093980 T3 ES 2093980T3 ES 93918065 T ES93918065 T ES 93918065T ES 93918065 T ES93918065 T ES 93918065T ES 2093980 T3 ES2093980 T3 ES 2093980T3
Authority
ES
Spain
Prior art keywords
teno
enzymatic
produce
reduction process
pct
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93918065T
Other languages
English (en)
Inventor
Robert Antony Holt
Stuart Richard Rigby
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Syngenta Ltd
Original Assignee
Zeneca Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26301521&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2093980(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB929218502A external-priority patent/GB9218502D0/en
Priority claimed from GB939303824A external-priority patent/GB9303824D0/en
Application filed by Zeneca Ltd filed Critical Zeneca Ltd
Application granted granted Critical
Publication of ES2093980T3 publication Critical patent/ES2093980T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P41/00—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/185—Heterocyclic compounds containing sulfur atoms as ring hetero atoms in the condensed system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P41/00—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
    • C12P41/002—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by oxidation/reduction reactions

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

UN COMPUESTO DE FORMULA (I) EN EL QUE X ES HIDROGENO O UN GRUPO DE FORMULA - SO2NH2, SE REDUCE A LA FORMA (4S, 6S) TRANS DEL ALCOHOL CORRESPONDIENTE, MEDIANTE UN SISTEMA DE REDUCCION ENZIMATICA.
ES93918065T 1992-08-28 1993-08-20 Proceso de reduccion asimetrica, enzimatica, para producir derivados de 4h-tieno(2,3-6)tiopirano. Expired - Lifetime ES2093980T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929218502A GB9218502D0 (en) 1992-08-28 1992-08-28 Asymmetric reduction process
GB939303824A GB9303824D0 (en) 1993-02-25 1993-02-25 Asymmetric reduction process

Publications (1)

Publication Number Publication Date
ES2093980T3 true ES2093980T3 (es) 1997-01-01

Family

ID=26301521

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93918065T Expired - Lifetime ES2093980T3 (es) 1992-08-28 1993-08-20 Proceso de reduccion asimetrica, enzimatica, para producir derivados de 4h-tieno(2,3-6)tiopirano.

Country Status (12)

Country Link
US (1) US5580764A (es)
EP (1) EP0658211B2 (es)
JP (1) JP3333206B2 (es)
KR (1) KR100319837B1 (es)
AT (1) ATE144795T1 (es)
AU (1) AU4729193A (es)
CA (1) CA2142444C (es)
DE (1) DE69305748T3 (es)
DK (1) DK0658211T4 (es)
ES (1) ES2093980T3 (es)
FI (1) FI106565B (es)
WO (1) WO1994005802A1 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3279671B2 (ja) * 1992-09-28 2002-04-30 鐘淵化学工業株式会社 チエノチオピラン誘導体の製造方法
US5474919A (en) * 1994-09-13 1995-12-12 Merck & Co., Inc. Bioconversion process for the synthesis of transhydroxy sulfone by Rhodotorula rubra or Rhodotorula piliminae
IL132500A0 (en) 1998-10-29 2001-03-19 Pfizer Prod Inc Stereoselective microbial reduction of a racemic tetralone
US6451587B1 (en) 1999-09-29 2002-09-17 Pfizer Inc. Microbial asymmetric reduction of 2-chloro-1-[-6-(2,5-dimethyl-pyrrol-1-yl)-pyridin-3-yl]-ethanone
ES2177415B1 (es) 2000-09-04 2004-10-16 Ragactives, S.L. Procedimiento para la obtencion de 4-alquilamino-5, 6-dihidro-4h-tieno-(2,3b)-tiopiran-2-sulfonamida-7-dioxidos, e intermedios.
US9097692B2 (en) * 2010-10-01 2015-08-04 Aug. Hedinger Gmbh & Co. Kg Method for quantitatively determining impurities in glycerin
ITMI20111028A1 (it) * 2011-06-08 2012-12-09 Zach System Spa Processo di riduzione asimmetrica
WO2012120086A1 (en) * 2011-03-10 2012-09-13 Zach System S.P.A. Asymmetric reduction process
ITMI20110365A1 (it) * 2011-03-10 2012-09-11 Zach System Spa Processo di riduzione asimmetrica
KR102019953B1 (ko) 2017-03-02 2019-11-04 (주)삼성컨트롤밸브 자동밸브를 이용한 분무 장치

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4863922A (en) * 1984-12-12 1989-09-05 Merck & Co., Inc. Substituted aromatic sulfonamides as antiglaucoma agents, compositions and use
US4968815A (en) * 1990-04-16 1990-11-06 Merck & Co., Inc. Synthesis of (S)-3-(thien-2-ylthio)butyric acid analogs
US5039802A (en) * 1990-04-18 1991-08-13 Merck & Co., Inc. Arylation process for preparation of chiral catalysts for ketone reduction
US5474919A (en) * 1994-09-13 1995-12-12 Merck & Co., Inc. Bioconversion process for the synthesis of transhydroxy sulfone by Rhodotorula rubra or Rhodotorula piliminae

Also Published As

Publication number Publication date
ATE144795T1 (de) 1996-11-15
KR100319837B1 (ko) 2002-04-22
EP0658211B2 (en) 2003-12-10
FI106565B (fi) 2001-02-28
FI950892A0 (fi) 1995-02-27
US5580764A (en) 1996-12-03
JPH08501216A (ja) 1996-02-13
DE69305748D1 (de) 1996-12-05
JP3333206B2 (ja) 2002-10-15
DE69305748T3 (de) 2004-07-29
DK0658211T3 (da) 1997-04-28
CA2142444C (en) 2008-08-05
EP0658211A1 (en) 1995-06-21
KR950703062A (ko) 1995-08-23
EP0658211B1 (en) 1996-10-30
FI950892A (fi) 1995-02-27
WO1994005802A1 (en) 1994-03-17
DK0658211T4 (da) 2004-04-13
CA2142444A1 (en) 1994-03-17
DE69305748T2 (de) 1997-03-13
AU4729193A (en) 1994-03-29

Similar Documents

Publication Publication Date Title
GB9108307D0 (en) Autoinducer
AU3262295A (en) Metalloproteinase inhibitors
EE03194B1 (et) Ühendid, nende kasutamine magustavate toimeainetena ja nende valmistamise meetod
DE69214466D1 (de) Polymerbeschichtung
ES2093980T3 (es) Proceso de reduccion asimetrica, enzimatica, para producir derivados de 4h-tieno(2,3-6)tiopirano.
GR1002573B (el) Μικροβιακη μεθοδος παρασκευης μεβινολινης.
GB9206768D0 (en) New compounds for use in the treatment of cancer
AU6709896A (en) Quinone compound, its production and use
BR9607493A (pt) Processo para preparar em composto
AU2713897A (en) Antiviral 2,4-pyrimidinedione derivatives and process for the preparation thereof
AU4787696A (en) Production of enantiomerically enriched ortho-substituted alpha,alpha-diaromatic methanols
CA2047714A1 (en) Process for fermentative production of 2-(4-hydroxyphenoxy-)propionic acid
MX9306995A (es) Derivados de acido orto-etenilfenilacetico sustituidos.
AU1600495A (en) Novel indane-2-mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase
ES2133414T3 (es) Derivados de amida.
AU7625096A (en) Production of a salt of clavulanic acid
AU5280399A (en) Method for producing (1r,4s)-2-azabicylco(2.2.1)hept-5-en-3-on derivatives
ATE213781T1 (de) Mikrobiologisches verfahren zur herstellung von (s,s) äthylendiamin-n,n'-di-bernsteinsäure
ZA95934B (en) Novel mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase and ace
DK0725785T3 (da) Fremgangsmåde til fremstilling af rufloxacin af deraf
MX9603450A (es) Procedimiento para la obtencion de aminotriazolinas substituidas.
EA200101091A1 (ru) Получение псевдомицина pseudomonas syringae
ES2066054T3 (es) Nuevo antibiotico.
AU7351787A (en) 2,2,6,6-diethylene-3-oxo-17-alpha-pregn-4-en-21,17- carbolactones
YU49004B (sh) LANOSTA-7,9-DIEN-3Гџ, 32-DIOL I POSTUPAK ZA NJEGOVO DOBIJANJE

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 658211

Country of ref document: ES